< Back to previous page
Researcher
Chantal Mathieu
- Disciplines:Endocrinology and metabolic diseases
Affiliations
- Clinical and Experimental Endocrinology (Division)
Member
From1 Oct 1999 → Today
Projects
1 - 10 of 75
- Continuous glucose monitoring for women with gestational diabetes: a randomized controlled trial: the CORDELIA studyFrom1 Jan 2024 → 29 Mar 2024Funding: Own budget, for example: patrimony, inscription fees, gifts
- European action for the Diagnosis of Early Non-clinical Type 1 diabetes For disease InterceptionFrom1 Nov 2023 → TodayFunding: Horizon Europe - Digital, Industry and Space
- Quality of diabetes care: the role of health dataFrom29 Mar 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Neutrophils: neglected as potential players in autoimmune type 1 diabetes initiation, progression, and perpetuationFrom1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
- Unique IsoPlexis technology for multiplexed single cell functional profilingFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Innovative strategies for screening, diagnosis and prevention of type 1 diabetes.From13 Dec 2022 → 15 Dec 2022Funding: BOF - various
- "SyneRegIm": exploring the SYNErgistic effect of β-cell REGeneration and emerging IMmune intervention strategies to prevent and/or reverse type 1 diabetesFrom1 Sep 2022 → TodayFunding: Foreign private sponsor - undefined
- The SERENA study: Semaglutide for the treatment of glucose intolerance in women with prior gestational diabetes: a double blind RCTFrom30 Aug 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Characterization of the dynamic immunophenotype during type 1 diabetes progression to identify predictive biomarkers of anti-CD3 mono- and combination therapy in disease prevention and reversal in miceFrom7 Aug 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Next-generation, multi-technology immune-monitoring and easy-access spectral flow cytometryFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
Publications
41 - 50 of 713
- Rationale and design of the phase 3a development programme (ONWARDS 1-6 trials) investigating once-weekly insulin icodec in diabetes(2023)
Authors: Chantal Mathieu
Pages: 331 - 341 - Diabetes registries and high-quality diabetes care(2023)
Authors: Chantal Mathieu
Pages: 70 - 72 - The European Diabetes Forum (EUDF): a forum for turning the tide on diabetes in Europe(2023)
Authors: Chantal Mathieu
Pages: 247 - 252 - Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trial(2023)
Authors: Steffen Fieuws, Chantal Mathieu, Pieter Gillard
Pages: 96 - 108 - The Belgian Diabetes in Pregnancy Follow-Up Study (BEDIP-FUS): A Multi-Centric Prospective Cohort Study on the Long-Term Metabolic Risk across Different Degrees of Gestational Glucose Intolerance: Methodology and Design(2023)
Authors: Lore Raets, Annouschka Laenen, Annick Bogaerts, Chantal Mathieu, Katrien Fouzia Benhalima
- Women in diabetes research: we can do better. Reply to Bonnefond A [letter](2023)
Authors: Chantal Mathieu
Pages: 408 - 409 - Biomarkers for the Diagnosis of Heart Failure in People with Diabetes: A Consensus Report from Diabetes Technology Society.(2023)
Authors: Chantal Mathieu
Pages: 65 - 79 - Continuous glucose monitoring and metrics for clinical trials: an international consensus statement(2023)
Authors: Chantal Mathieu
Pages: 42 - 57 - Gestational diabetes: an opportunity to improve maternal health and well-being in pregnancy and beyond(2022)
Authors: Caro Minschart, Katrien Fouzia Benhalima, Annick Bogaerts, Chantal Mathieu
- De ADA/EASD consensus 2022 en de implicaties voor België(2022)
Authors: Ann Mertens, Chantal Mathieu
Pages: 6 - 10
Patents
1 - 6 of 6
- Biomarkers for diabetes therapy (Inventor)
- Biomarkers for diabetes therapy (Inventor)
- Improved methods for pancreatic islet transplantation (Inventor)
- Citrullinated peptides for diagnosis or treatment of diabetes (Inventor)
- Improved methods for pancreatic islet transplantation (Inventor)
- RESISTANCE TO OXIDATIVE STRESS (Inventor)